Zon RT - Search Results

1

Safe Handling of Hazardous Drugs: ASCO Standards.

Celano P, Fausel CA, Kennedy EB, Miller TM, Oliver TK, Page R, Ward JC, Zon RT. Celano P, et al. Among authors: zon rt. J Clin Oncol. 2019 Mar 1;37(7):598-609. doi: 10.1200/JCO.18.01616. Epub 2019 Jan 8. J Clin Oncol. 2019. PMID: 30620670

2

American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.

Zon R, Meropol NJ, Catalano RB, Schilsky RL. Zon R, et al. J Clin Oncol. 2008 May 20;26(15):2562-7. doi: 10.1200/JCO.2007.15.6398. Epub 2008 Apr 7. J Clin Oncol. 2008. PMID: 18390967

3

American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.

Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, Wollins DS, Garber JE, Brown P, Kramer BS; American Society of Clinical Oncology. Zon RT, et al. J Clin Oncol. 2009 Feb 20;27(6):986-93. doi: 10.1200/JCO.2008.16.3691. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075281 Free PMC article.

4

American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.

Zon RT, Frame JN, Neuss MN, Page RD, Wollins DS, Stranne S, Bosserman LD. Zon RT, et al. J Oncol Pract. 2016 Mar;12(3):261-6. doi: 10.1200/JOP.2015.009134. Epub 2016 Jan 12. J Oncol Pract. 2016. PMID: 26759491

5

Summary of the Workshop on the Safe Handling of Hazardous Drugs Cohosted by the National Institute for Occupational Safety and Health and the American Society of Clinical Oncology.

Connor TH, Celano P, Frame JN, Zon RT. Connor TH, et al. Among authors: zon rt. J Oncol Pract. 2017 Mar;13(3):199-205. doi: 10.1200/JOP.2016.017384. Epub 2017 Feb 21. J Oncol Pract. 2017. PMID: 28221893 No abstract available.

6

American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in Oncology.

Zon RT, Edge SB, Page RD, Frame JN, Lyman GH, Omel JL, Wollins DS, Green SR, Bosserman LD. Zon RT, et al. J Oncol Pract. 2017 Mar;13(3):207-210. doi: 10.1200/JOP.2016.019836. Epub 2017 Feb 7. J Oncol Pract. 2017. PMID: 28282276 No abstract available.

7

Oncology Clinical Pathways: Charting the Landscape of Pathway Providers.

Daly B, Zon RT, Page RD, Edge SB, Lyman GH, Green SR, Wollins DS, Bosserman LD. Daly B, et al. Among authors: zon rt. J Oncol Pract. 2018 Mar;14(3):e194-e200. doi: 10.1200/JOP.17.00033. Epub 2018 Feb 7. J Oncol Pract. 2018. PMID: 29412768 No abstract available.

8

When Investment Meets Return.

Zon R, Page R. Zon R, et al. J Oncol Pract. 2018 Mar;14(3):147-148. doi: 10.1200/JOP.2017.027060. Epub 2018 Feb 7. J Oncol Pract. 2018. PMID: 29412769 No abstract available.

9

American Society of Clinical Oncology Statement: Biosimilars in Oncology.

Lyman GH, Balaban E, Diaz M, Ferris A, Tsao A, Voest E, Zon R, Francisco M, Green S, Sherwood S, Harvey RD, Schilsky RL. Lyman GH, et al. J Clin Oncol. 2018 Apr 20;36(12):1260-1265. doi: 10.1200/JCO.2017.77.4893. Epub 2018 Feb 14. J Clin Oncol. 2018. PMID: 29443651 Review.

10

Reply to S.D. Lucio.

Lyman GH, Zon R, Harvey RD, Schilsky RL. Lyman GH, et al. J Clin Oncol. 2018 Jul 10;36(20):2127. doi: 10.1200/JCO.2018.79.1780. Epub 2018 May 30. J Clin Oncol. 2018. PMID: 29847292 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters